SGB and Teeny Tiny Science: The Partnership That Changed the Edible
In May 2021, Supergalactic Brands announced its incubation and strategic investment in Teeny Tiny Science — a startup founded by Dr. Noel Palmer with a specific thesis: that the cannabis edible experience was fundamentally broken, and that science could fix it.
The thesis was correct. And the partnership that formed around it became the technology foundation for everything SGB has built since.
The Problem TTS Solved
Traditional cannabis edibles metabolize through the liver, converting Delta-9 THC into 11-Hydroxy THC — a metabolite with a different, often unpredictable effect profile. The onset is slow. The duration is long. The experience varies dramatically between individuals. None of that is a product design — it's a limitation of the delivery mechanism.
TTS's nano-emulsification technology bypasses that pathway. By encapsulating cannabinoid and terpene molecules in a water-soluble shell at a controlled particle size, TTS enables direct absorption into the bloodstream — faster onset, more consistent effect, and predictable duration that mirrors inhalation without the act of inhalation.
Most edible companies work around the liver. TTS found a way to make the liver irrelevant.
From Startup to Platform
What began as a partnership became infrastructure. The TTS platform now powers Orchard's 15-minute onset claim, Herb and Lou's clean-offset formula, and Zingiez's fast-acting chewable experience. Dr. Noel Palmer serves as Chief Scientist at SGB. The science that started in a lab in 2021 now runs through the entire portfolio.